Disparities in absolute denial of modern hepatitis C therapy by type of insurance | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Disparities in absolute denial of modern hepatitis C therapy by type of insurance

Lo Re V, Gowda C, Urick PN, et al. Disparities in absolute denial of modern hepatitis C therapy by type of insurance. Clin Gastroenterol Hepatol. 2016;14(7):1035-1043.

Publication Type:

Journal Article

Authors:

Vincent Lo Re; Gowda, Charitha; Urick, Paul N.; et, al

Source:

Clin Gastroenterol Hepatol, Volume 14, Issue 7, p.1035-1043 (2016)

Keywords:

Aged, Antiviral Agents, Direct-Acting Antiviral, Female, Health Services Accessibility, Hepatitis C, Hepatitis C, Chronic, Humans, Insurance, Insurance, Health, Male, Middle Aged, Prospective Studies, United States

Cited On:

Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/27062903

Export Citation:

RIS Format

Top